Kopran Limited (BSE: 524280)
Health Care · Pharmaceuticals · IN
Rs271.00
+7.84% today · +62.9% 1Y
Kopran Limited (BSE: 524280) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $137.88M.
Over the last twelve months the share price has gained 62.9%, trading between 107.00 and 295.90.
Tweenvest scores Kopran Limited across four factors: quality 72/100, value 18/100, growth 20/100, dividend 27/100. Its strongest factor is quality.
524280 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $137.88M
- Revenue (TTM)
- $74.05M
- P/E
- 52.38
- EPS
- 5.17
- Dividend yield
- 1.11%
- Beta (5Y)
- 0.89
- 52-week high
- Rs295.90
- 52-week low
- Rs107.00
- Avg volume (3M)
- —
- Shares outstanding
- 48.29M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| SunWay Biotech Co., LTD.TPEX: 1271 | $141.29M | NT$59.70 | +1.53% |
| Cuu Long Pharmaceutical Joint Stock CompanyHOSE: DCL | $141.04M | ₫50,000.00 | +2.46% |
| Hoechst Pakistan LimitedKASE: HPL | $140.65M | PKRs4,035.00 | +1.85% |
| Journey Medical CorporationNasdaqCM: DERM | $140.13M | $4.97 | -21.32% |
| REYON Pharmaceutical Co., Ltd.KOSE: A102460 | $136.47M | ₩9,920.00 | -3.50% |
| Memphis Pharmaceuticals & Chemical IndustriesCASE: MPCI | $134.99M | EGP317.03 | -8.38% |
| Hyloris Pharmaceuticals SAENXTBR: HYL | $134.82M | €4.28 | +15.05% |
| Astena Holdings Co., Ltd.TSE: 8095 | $133.93M | ¥523.00 | -4.04% |
Figures last refreshed Oct 11, 2026.